Russell C Dale Selected Research

Russell C Dale Research Topics

Disease

43	Encephalitis (Encephalitis, Rasmussen) 01/2024 - 01/2004
22	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 02/2007
21	Seizures (Absence Seizure) 01/2023 - 06/2008
20	Inflammation (Inflammations) 11/2023 - 04/2009
16	Brain Diseases (Brain Disorder) 01/2023 - 06/2009
16	Autoimmune Diseases of the Nervous System 03/2021 - 09/2010
15	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2024 - 10/2005
15	Neuromyelitis Optica (Devic's Disease) 01/2023 - 06/2009
14	Multiple Sclerosis 01/2023 - 02/2007
14	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2021 - 05/2014
12	Chorea (Rheumatic Chorea) 04/2024 - 03/2003
11	Optic Neuritis (Retrobulbar Neuritis) 01/2024 - 06/2009
11	Movement Disorders (Movement Disorder) 01/2024 - 09/2010
11	Epilepsy (Aura) 05/2023 - 06/2003
11	Neuroinflammatory Diseases 05/2023 - 07/2014
9	Central Nervous System Diseases (CNS Diseases) 01/2017 - 06/2003
8	Infections 01/2023 - 07/2014
8	Dystonia (Limb Dystonia) 11/2022 - 04/2009
7	Nervous System Diseases (Neurological Disorders) 06/2024 - 11/2011
7	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 06/2009
6	Parkinsonian Disorders (Parkinsonism) 11/2022 - 06/2011
6	Glioma (Gliomas) 10/2021 - 11/2011
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2021 - 06/2003
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 11/2011
5	Disease Progression 02/2022 - 12/2014
5	Mental Disorders (Mental Disorder) 01/2020 - 11/2012
4	Stroke (Strokes) 01/2023 - 01/2019
4	Herpes Simplex Encephalitis (Herpes Encephalitis) 03/2022 - 04/2007
4	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 06/2003
4	Human Influenza (Influenza) 01/2019 - 01/2004
4	Ataxia (Dyssynergia) 11/2017 - 06/2003
4	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 08/2011
3	Ischemic Stroke 03/2024 - 01/2019
3	Leukocytosis (Pleocytosis) 05/2023 - 04/2009
3	Spasm (Spasms) 10/2022 - 11/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 08/2010
3	Myasthenia Gravis 01/2021 - 03/2011
3	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2020 - 11/2012
3	Myoclonic dystonia 01/2019 - 08/2011
3	Myelitis 01/2019 - 04/2009
3	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018 - 08/2010
3	Dyskinesias (Dyskinesia) 04/2017 - 01/2013
2	COVID-19 01/2024 - 01/2021
2	Aseptic Meningitis 12/2022 - 01/2013
2	Hyperkinesis 11/2022 - 04/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 07/2007
2	Autism Spectrum Disorder 01/2022 - 12/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 10/2005
2	Tourette Syndrome (Tourette's Syndrome) 01/2022 - 11/2012

Drug/Important Bio-Agent (IBA)

43	AntibodiesIBA 01/2024 - 06/2003
39	AutoantibodiesIBA 01/2024 - 03/2003
30	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 11/2009
26	Myelin-Oligodendrocyte GlycoproteinIBA 01/2024 - 12/2009
22	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2009
16	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2011
12	Immunoglobulin G (IgG)IBA 01/2024 - 04/2007
11	CytokinesIBA 12/2022 - 01/2016
9	SteroidsIBA 12/2022 - 05/2004
8	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 08/2009
8	NeopterinIBA 05/2023 - 04/2009
8	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 06/2003
8	AntigensIBA 01/2021 - 12/2009
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2016 - 11/2011
6	Leucine (L-Leucine)FDA Link 10/2021 - 11/2011
6	ChemokinesIBA 01/2019 - 01/2016
5	EpitopesIBA 01/2024 - 10/2013
5	KynurenineIBA 05/2023 - 01/2021
5	Rituximab (Mabthera)FDA Link 10/2021 - 06/2011
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2013
5	Oligoclonal BandsIBA 04/2015 - 11/2007
5	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 11/2007
4	Tryptophan (L-Tryptophan)FDA Link 05/2023 - 01/2021
4	Quinolinic AcidIBA 05/2023 - 01/2021
4	Kynurenic Acid (Kynurenate)IBA 05/2023 - 01/2021
4	N-Methylaspartate (NMDA)IBA 03/2022 - 09/2010
4	InterferonsIBA 01/2022 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2016
3	Glycine Receptors (Glycine Receptor)IBA 01/2024 - 12/2013
3	AutoantigensIBA 01/2023 - 03/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2004
3	AcidsIBA 01/2021 - 01/2015
3	Aminobutyrates (Aminobutyric Acid)IBA 01/2020 - 01/2015
3	Antiviral Agents (Antivirals)IBA 11/2017 - 10/2012
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016 - 06/2013
3	Surface Antigens (Surface Antigen)IBA 01/2015 - 06/2011
2	C-Reactive ProteinIBA 01/2024 - 05/2015
2	Interleukin-10 (Interleukin 10)IBA 12/2022 - 01/2016
2	Dopamine Agents (Dopaminergic Agents)IBA 11/2022 - 11/2007
2	Arginine (L-Arginine)FDA Link 03/2022 - 01/2021
2	anthranilic acid (anthranilate)IBA 03/2022 - 01/2021
2	CitrullineIBA 03/2022 - 01/2021
2	3-Hydroxyanthranilic AcidIBA 03/2022 - 01/2021
2	Immunoglobulin A (IgA)IBA 01/2022 - 03/2015

Therapy/Procedure

27	Therapeutics 06/2024 - 06/2003
11	Immunotherapy 04/2024 - 11/2011
4	Deep Brain Stimulation 11/2022 - 04/2017
4	Plasma Exchange 08/2016 - 06/2011
2	Thrombectomy 03/2024 - 01/2023
2	Ketogenic Diet 11/2022 - 10/2022